High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
High-Throughput Microfluidic 3D Cytotoxicity Assay for Cancer Immunotherapy (CACI-IMPACT Platform)
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-05-28
DOI
10.3389/fimmu.2019.01133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The potential role of γδ T cells after allogeneic HCT for leukemia
- (2018) Rupert Handgretinger et al. BLOOD
- TGF-β Inhibition and Immunotherapy: Checkmate
- (2018) Karuna Ganesh et al. IMMUNITY
- Microfluidics within a well: an injection-molded plastic array 3D culture platform
- (2018) Younggyun Lee et al. LAB ON A CHIP
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- CAR-T cells: the long and winding road to solid tumors
- (2018) Maria Michela D’Aloia et al. Cell Death & Disease
- Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model
- (2018) Sharon Wei Ling Lee et al. Frontiers in Immunology
- Tissue Force Programs Cell Fate and Tumor Aggression
- (2017) Jason J. Northey et al. Cancer Discovery
- Cytotoxic T Cells Use Mechanical Force to Potentiate Target Cell Killing
- (2016) Roshni Basu et al. CELL
- Microfluidic models for adoptive cell-mediated cancer immunotherapies
- (2016) Giulia Adriani et al. DRUG DISCOVERY TODAY
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Physical limits of cell migration: Control by ECM space and nuclear deformation and tuning by proteolysis and traction force
- (2013) Katarina Wolf et al. JOURNAL OF CELL BIOLOGY
- Microfluidic platforms for mechanobiology
- (2013) William J. Polacheck et al. LAB ON A CHIP
- Engineering of functional, perfusable 3D microvascular networks on a chip
- (2013) Sudong Kim et al. LAB ON A CHIP
- Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
- (2012) Hélène Salmon et al. JOURNAL OF CLINICAL INVESTIGATION
- Microfluidic assay for simultaneous culture of multiple cell types on surfaces or within hydrogels
- (2012) Yoojin Shin et al. Nature Protocols
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- (2010) J. N. Kochenderfer et al. BLOOD
- Intravital Imaging Reveals Distinct Dynamics for Natural Killer and CD8+ T Cells during Tumor Regression
- (2010) Jacques Deguine et al. IMMUNITY
- Collagen-based cell migration models in vitro and in vivo
- (2009) Katarina Wolf et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started